NM_000844.4:c.1034-35C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000844.4(GRM7):c.1034-35C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.723 in 1,558,222 control chromosomes in the GnomAD database, including 410,241 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.74 ( 41504 hom., cov: 30)
Exomes 𝑓: 0.72 ( 368737 hom. )
Consequence
GRM7
NM_000844.4 intron
NM_000844.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -3.97
Publications
10 publications found
Genes affected
GRM7 (HGNC:4599): (glutamate metabotropic receptor 7) L-glutamate is the major excitatory neurotransmitter in the central nervous system, and it activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors that have been divided into three groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5, and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3, while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2009]
GRM7 Gene-Disease associations (from GenCC):
- neurodevelopmental disorder with seizures, hypotonia, and brain imaging abnormalitiesInheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.821 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.735 AC: 111502AN: 151730Hom.: 41449 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
111502
AN:
151730
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.689 AC: 155322AN: 225290 AF XY: 0.694 show subpopulations
GnomAD2 exomes
AF:
AC:
155322
AN:
225290
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.722 AC: 1014867AN: 1406374Hom.: 368737 Cov.: 23 AF XY: 0.721 AC XY: 503358AN XY: 697958 show subpopulations
GnomAD4 exome
AF:
AC:
1014867
AN:
1406374
Hom.:
Cov.:
23
AF XY:
AC XY:
503358
AN XY:
697958
show subpopulations
African (AFR)
AF:
AC:
26141
AN:
31216
American (AMR)
AF:
AC:
20570
AN:
38512
Ashkenazi Jewish (ASJ)
AF:
AC:
17579
AN:
24654
East Asian (EAS)
AF:
AC:
21258
AN:
38058
South Asian (SAS)
AF:
AC:
56074
AN:
80212
European-Finnish (FIN)
AF:
AC:
35648
AN:
52658
Middle Eastern (MID)
AF:
AC:
4032
AN:
5428
European-Non Finnish (NFE)
AF:
AC:
791732
AN:
1077610
Other (OTH)
AF:
AC:
41833
AN:
58026
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
11344
22688
34031
45375
56719
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
19626
39252
58878
78504
98130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.735 AC: 111615AN: 151848Hom.: 41504 Cov.: 30 AF XY: 0.731 AC XY: 54221AN XY: 74202 show subpopulations
GnomAD4 genome
AF:
AC:
111615
AN:
151848
Hom.:
Cov.:
30
AF XY:
AC XY:
54221
AN XY:
74202
show subpopulations
African (AFR)
AF:
AC:
34353
AN:
41458
American (AMR)
AF:
AC:
9506
AN:
15220
Ashkenazi Jewish (ASJ)
AF:
AC:
2467
AN:
3470
East Asian (EAS)
AF:
AC:
2757
AN:
5136
South Asian (SAS)
AF:
AC:
3337
AN:
4802
European-Finnish (FIN)
AF:
AC:
7281
AN:
10538
Middle Eastern (MID)
AF:
AC:
218
AN:
294
European-Non Finnish (NFE)
AF:
AC:
49464
AN:
67916
Other (OTH)
AF:
AC:
1525
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
1471
2943
4414
5886
7357
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
838
1676
2514
3352
4190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2350
AN:
3476
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.